Deborah Brauser

News

FDA approves first oral treatment for spinal muscular atrophy

Author:: Deborah Brauser

Publish date: August 11, 2020

The oral treatment provided a “meaningful difference from the natural progression of the disease.”

News

Topline results for novel intranasal med to treat opioid overdose

Author:: Deborah Brauser

Publish date: July 1, 2020

Like naloxone, nalmefene is an opioid...

News

FDA approves apomorphine sublingual film for ‘off’ episodes in Parkinson’s disease

Author:: Deborah Brauser

Publish date: May 27, 2020

This marks the first approval for a sublingual therapy for this indication.

News

Depression linked to neuro dysfunction, brain lesions in MS

Author:: Deborah Brauser

Publish date: May 13, 2020

“Depression isn’t just a neuropsychiatric disease,” said Dr. Jenny Feng.

News

COVID-19: Dramatic changes to telepsychiatry rules and regs

Author:: Deborah Brauser

Publish date: April 8, 2020

“Clinicians need to be aware of these changes so they can ensure they are reaching as many people as possible,” said Dr. John Torous.

News

Another round of research shows ketamine may help alcoholism

Author:: Deborah Brauser

Publish date: February 14, 2020

During the 21 days after treatment infusion, 17.6% of those in the ketamine had a heavy drinking day, compared with 40.9% of those in the midazolam...

News

Seminal, highly anticipated Alzheimer’s trial falters

Author:: Deborah Brauser

Publish date: February 12, 2020

Negative top-line results for the phase 2/3 Dominantly Inherited Alzheimer’s Network–Trials Unit study of gantenerumab and solanezumab are disappoi...

News

FDA okays cenobamate (Xcopri) for focal epilepsy

Author:: Deborah Brauser

Publish date: November 22, 2019

Every story needs a teaser. Must differ from the headline. Meeting stories need a dateline. 150 characters or fewer.